Benjamin P. Martin
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Microtubule and mitosis dynamics, Histone Deacetylase Inhibitors Research, Ubiquitin and proteasome pathways
Most-Cited Works
- → BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1(2017)296 cited
- → HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses(2013)194 cited
- → CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo(2014)142 cited
- → Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor–induced thrombocytopenia(2011)134 cited
- → Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors(2014)133 cited
- → BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members(2016)73 cited
- → Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas(2013)68 cited
- → Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene(2017)54 cited
- → Synthesis and Kinetic Evaluation of Cyclophostin and Cyclipostins Phosphonate Analogs As Selective and Potent Inhibitors of Microbial Lipases(2012)51 cited
- → The role of p21waf1/cip1 and p27Kip1 in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma(2013)49 cited